4.6 Editorial Material

Long COVID: aiming for a consensus

Journal

LANCET RESPIRATORY MEDICINE
Volume 10, Issue 7, Pages 632-634

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S2213-2600(22)00135-7

Keywords

-

Funding

  1. British Embassy in Moscow
  2. UKRI/NIHR
  3. Russian Foundation

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Dermatology

Improvements and advances in core outcome set methodology: proceedings of the CS-COUSIN & COMFA Joint Meeting

McKenzie A. Dirr, Murad Alam, Christian Apfelbacher, Karl-Philipp Drewitz, Bianca Y. Kang, Daniel Munblit, Nikita Nekliudov, Nina Seylanova

Summary: The virtual meeting brought together developers of core outcome sets (COS) in the fields of dermatology and food allergy, assessing the current state of COS methodology and laying the groundwork for future projects. The conference emphasized the importance of ongoing COS work to improve patient outcomes and reduce research waste.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2023)

Letter Allergy

Trends in specialized low-allergy infant formula dispensing in Ireland: 2016-2021

Daniel O'Reilly, Robert Conway, Claire A. Murphy, Daniel Munblit, Patrick Fitzpatrick

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Review Allergy

Endpoints and Outcomes After Immunotherapy for Food Allergy: What Is Meaningful for Patients?

Melanie Lloyd, Nandinee Patel, Daniel Munblit, Mimi L. K. Tang

Summary: Multiple novel interventions for food allergy are currently in development, aiming to reduce or eliminate allergic reactions. However, the success of these therapies in improving patients' lives is difficult to determine due to limited understanding of the alignment between clinical trial efficacy endpoints and patient-centered outcomes. This review assists clinicians in interpreting clinical trial outcomes and effectively communicating risks and outcomes to patients during shared decision-making. (c) 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:998-1007)

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Review Allergy

Formula milk companies and allergy healthcare professionals in India

Hilary Allen, Arun Gupta, Alexandra Mundell, Neeraj Gupta, Anup Thakur, Sowmya Nagarajan, Daniel Munblit, Phillip Baker, Robert Boyle

Summary: India is a low-middle income country with a population of 1.4 billion and home to one quarter of the world's children. Exclusive breastfeeding until 6 months and continued breastfeeding until at least 2 years as per global recommendations are common practice. The Indian government and associated organisations have strived to protect breastfeeding, which is important in a country with high under-5 mortality, malnutrition and stunting.

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Review Allergy

Outcomes reported in randomized controlled trials for mixed and non-IgE-mediated food allergy: Systematic review

Manal Bel Imam, Charalampos-Vlasios Stikas, Payal Guha, Bo L. Chawes, Derek Chu, Matthew Greenhawt, Ekaterina Khaleva, Daniel Munblit, Nikita Nekliudov, Willem van de Veen, Ann-Marie M. Schoos

Summary: Background: Mixed and non-IgE-mediated food allergy can greatly impact the quality of life for patients and their families. This study aimed to assess the outcomes reported in clinical trials for these conditions, and found that the current reporting is inconsistent and lacks validation. It highlights the need for the development of core outcome measures to support effective treatments.

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Letter Immunology

Potential utility of calculated globulin as a screening tool for antibody deficiency in children

Ekaterina Spiridonova, Polina Bobkova, Marina Tyrykina, Valeria Kartashova, Yuriy Nikitin, Mikhail Gushchin, Irina Skibo, Anton Vasiliev, Irina Turina, Yulia Ivanova, Roman Gerovich, Vilana Kovygina, Oleg Blyuss, Daniel Munblit, Ilya Korsunskiy

IMMUNOLOGY LETTERS (2023)

Article Public, Environmental & Occupational Health

Characteristics and outcomes of an international cohort of 600000 hospitalized patients with COVID-19

Christiana Kartsonaki, J. Kenneth Baillie, Noelia Garcia Barrio, Joaquin Baruch, Abigail Beane, Lucille Blumberg, Fernando Bozza, Tessa Broadley, Aidan Burrell, Gail Carson, Barbara Wanjiru Citarella, Andrew Dagens, Emmanuelle A. Dankwa, Christl A. Donnelly, Jake Dunning, Loubna Elotmani, Martina Escher, Nataly Farshait, Jean-Christophe Goffard, Bronner P. Goncalves, Matthew Hall, Madiha Hashmi, Benedict Sim Lim Heng, Antonia Ho, Waasila Jassat, Miguel Pedrera Jimenez, Cedric Laouenan, Samantha Lissauer, Ignacio Martin-Loeches, France Mentre, Laura Merson, Ben Morton, Daniel Munblit, Nikita A. Nekliudov, Alistair D. Nichol, Budha Charan Singh Oinam, David Ong, Prasan Kumar Panda, Michele Petrovic, Mark G. Pritchard, Nagarajan Ramakrishnan, Grazielle Viana Ramos, Claire Roger, Oana Sandulescu, Malcolm G. Semple, Pratima Sharma, Louise Sigfrid, Emily C. Somers, Anca Streinu-Cercel, Fabio Taccone, Pavan Kumar Vecham, Bharath Kumar Tirupakuzhi Vijayaraghavan, Jia Wei, Evert-Jan Wils, Xin Ci Wong, Peter Horby, Amanda Rojek, Piero L. Olliaro, Ali Abbas

Summary: This study analyzed demographic features, treatments, and clinical outcomes of hospitalized COVID-19 patients in 52 countries from January 2020 to January 2022. Age and male sex were associated with a higher risk of death. Symptoms, co-morbidities, and treatments were associated with clinical outcomes. This comprehensive international study provides valuable information for prioritizing treatment for COVID-19 patients at higher risk of death.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2023)

Review Allergy

Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach

Matthew Greenhawt, Timothy E. Dribin, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David B. K. Golden, Cem Akin, Akterini Anagnostou, Faisal Almuhizi, Waleed Alqurashi, Peter Arkwright, James L. Baldwin, Aleena Banerji, Philippe Begin, Moshe Ben-Shoshan, Jonathan Bernstein, Theresa A. Bingemann, Carsten Bindslev-Jensen, Kim Blumenthal, Aideen Byrne, Julia Cahill, Scott Cameron, Dianne Campbell, Ronna Campbell, Michael Cavender, Edmond S. Chan, Sharon Chinthrajah, Pasquale Comberiati, Jacqueline J. Eastman, Anne K. Ellis, David M. Fleischer, Adam Fox, Pamela A. Frischmeyer-Guerrerio, Remi Gagnon, Lene H. Garvey, Mitchell H. Grayson, Ghislaine Annie Clarisse Isabwe, Nicholas Hartog, David Hendron, Caroline C. Horner, Johnathan O'B Hourihane, Edward Iglesia, Manstein Kan, Blanka Kaplan, Constance H. Katelaris, Harold Kim, John M. Kelso, David A. Khan, David Lang, Dennis Ledford, Michael Levin, Jay A. Lieberman, Richard Loh, Douglas P. Mack, Bruce Mazer, Ketan Mody, Gisele Mosnaim, Daniel Munblit, S. Shahzad Mustafa, Anil Nanda, Richard Nathan, John Oppenheimer, Iris M. Otani, Miguel Park, Ruby Pawankar, Kirsten P. Perrett, Jonny Peter, Elizabeth J. Phillips, Matthieu Picard, Mitchell Pitlick, Allison Ramsey, Trine Holm Rasmussen, Melinda M. Rathkopf, Hari Reddy, Kara Robertson, Pablo Rodriguez del Rio, Stephen Sample, Ajay Sheshadri, Javed Sheik, Sayantani B. Sindher, Jonathan M. Spergel, Cosby A. Stone, David Stukus, Mimi L. K. Tang, James M. Tracy, Paul J. Turner, Timothy K. Vander Leek, Dana V. Wallace, Julie Wang, Susan Wasserman, David Weldon, Anna R. Wolfson, Margitta Worm, Mona-Rita Yacoub

Summary: This guidance provides updates on immediate allergic reactions following COVID-19 vaccines, including recommendations for revaccinating individuals with first-dose allergic reactions and conducting allergy testing. The recommendations were formed by an international panel of experts and are based on recent meta-analyses and diagnostic accuracy studies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Review Immunology

Systematic Review of the Prevalence of Long COVID

Mirembe Woodrow, Charles Carey, Nida Ziauddeen, Rebecca Thomas, Athena Akrami, Vittoria Lutje, Darren C. Greenwood, Nisreen A. Alwan

Summary: A review of 130 publications found that the prevalence of Long COVID (>12 weeks) after SARS-CoV-2 infection varied depending on how symptoms were identified and measured, ranging from 0% to 93% (pooled estimate, 42.1%; 95% prediction interval, 6.8%-87.9%).

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Rheumatology

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

Samuel Channon-Wells, Ortensia Vito, Andrew J. McArdle, Eleanor G. Seaby, Harsita Patel, Priyen Shah, Ekaterina Pazukhina, Clare Wilson, Claire Broderick, Giselle D'Souza, Ilana Keren, Ruud G. Nijman, Adriana Tremoulet, Daniel Munblit, Rolando Ulloa-Gutierrez, Michael J. Carter, Padmanabhan Ramnarayan, Tisham De, Clive Hoggart, Elizabeth Whittaker, Jethro A. Herberg, Myrsini Kaforou, Aubrey J. Cunnington, Oleg Blyuss, Michael Levin

Summary: This study evaluated immunomodulatory treatments for multisystem inflammatory syndrome in children (MIS-C) and found that glucocorticoids or glucocorticoids plus intravenous immunoglobulin were not significantly different from intravenous immunoglobulin alone in terms of clinical efficacy. Initial treatment with glucocorticoids may be a safe alternative to immunoglobulin or combined therapy.

LANCET RHEUMATOLOGY (2023)

Article Medicine, General & Internal

Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study

Rosa Morello, Francesco Mariani, Luca Mastrantoni, Cristina De Rose, Giuseppe Zampino, Daniel Munblit, Louise Sigfrid, Piero Valentini, Danilo Buonsenso

Summary: The purpose of this study was to investigate the risk factors and longitudinal recovery rates of post-Covid-19 condition (PCC) in children and young people. The results showed that age, comorbidities, and hospitalization during the acute phase were associated with PCC. Most children recovered over time, but 5% of patients still had persistent symptoms 18 months after Sars-CoV-2 infection. Omicron infection was associated with shorter recovery times, and vaccination did not have a strong protective effect on PCC development. Therefore, new strategies are needed to prevent and treat pediatric PCC.

ECLINICALMEDICINE (2023)

Article Allergy

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Youn Ho Shin, Jimin Hwang, Rosie Kwon, Seung Won Lee, Min Seo Kim, Jae Il Shin, Dong Keon Yon

Summary: This study evaluates the global, regional, national, and temporal trends of the burden of asthma and atopic dermatitis (AD) from 1990 to 2019. It found that both conditions have increased in prevalence, especially among young people and in high-SDI countries.

ALLERGY (2023)

Review Medicine, General & Internal

Association of breastfeeding with mental disorders in mother and child: a systematic review and meta-analysis

Polina Bugaeva, Inna Arkusha, Rinat Bikaev, Igor Kamenskiy, Aleksandra Pokrovskaya, Yasmin El-Taravi, Valeria Caso, Alla Avedisova, Derek K. Chu, Jon Genuneit, Gabriel Torbahn, Timothy R. Nicholson, Dina Baimukhambetova, Aigun Mursalova, Anastasia Kolotilina, Svetlana Gadetskaya, Elena Kondrikova, Mikhail Zinchuk, Renat Akzhigitov, Robert J. Boyle, Alla Guekht, Daniel Munblit

Summary: This study systematically evaluated the association between breastfeeding and mental health disorders in mothers and children, and found limited evidence to support a protective association between breastfeeding and the development of mental health disorders in children later in life. The data regarding the association between breastfeeding and maternal mental health beyond the postnatal period is also limited.

BMC MEDICINE (2023)

Review Pediatrics

Intranasal analgesia for acute moderate to severe pain in children - a systematic review and meta-analysis

Marcus Glenton Prescott, Ekaterina Iakovleva, Melanie Rae Simpson, Sindre Andre Pedersen, Daniel Munblit, Odd Martin Vallersnes, Bjarne Austad

Summary: This study compares the efficacy, safety, and acceptability of intranasal analgesia to intravenous and intramuscular administration in children with acute pain. The findings suggest that intranasal analgesics may be a good alternative to intramuscular analgesics and may also be an alternative to intravenous administration.

BMC PEDIATRICS (2023)

Editorial Material Medicine, General & Internal

Long COVID in low-income and middle-income countries: the hidden public health crisis

Waasila Jassat, Luis Felipe Reyes, Daniel Munblit, Janice Caoili, Fernando Bozza, Madiha Hashmi, Michael Edelstein, Cheryl Cohen, Carlos A. Alvarez-Moreno, Bin Cao

LANCET (2023)

No Data Available